Search Results

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

Authors: Alvarez, Paulino A.; Pahissa, Jaime

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 97-104(8)

Publisher: Bentham Science Publishers

The prefrontal cortex: a target for antipsychotic drugs

Author: Artigas, F.

Source: Acta Psychiatrica Scandinavica, Volume 121, Number 1, January 2010 , pp. 11-21(11)

Publisher: Blackwell Publishing

Iloperidone: a new option for the treatment of schizophrenia

Author: Cutler, Andrew J

Source: Expert Review of Neurotherapeutics, Volume 9, Number 12, December 2009 , pp. 1727-1741(15)

Publisher: Expert Reviews

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

Authors: Bushe, C. J.; Bradley, A. J.; Doshi, S.; Karagianis, J.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1743-1761(19)

Publisher: Blackwell Publishing

Sudden death in patients receiving drugs tending to prolong the QT interval

Authors: Jolly, Kate; Gammage, Michael D.; Cheng, Kar Keung; Bradburn, Peter; Banting, Miriam V.; Langman, Michael J. S.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 743-751(9)

Publisher: Blackwell Publishing

Relapse and Long-Acting Injectable Risperidone: A 1-Year Mirror Image Study with a National Claims Database in Taiwan

Authors: Su, Kuan-Pin; Chang, Hui-Chih; Tsai, Shih-Jen; Yen, Feng-Chang; Tang, Chao-Hsiun

Source: Value in Health, Volume 12, Supplement 3, November/December 2009 , pp. S118-S121(1)

Publisher: Blackwell Publishing

Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

Authors: Aubry, Jean-Michel; Schwald, Michèle; Ballmann, Eladia; Karege, Félicien

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 419-429(11)

Publisher: Springer

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study

Authors: Pouwels, S.; Staa, T.; Egberts, A.; Leufkens, H.; Cooper, C.; Vries, F.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1499-1506(8)

Publisher: Springer

Aggressive Behaviour in Adults with Intellectual Disability: Defining the Role of Drug Treatment

Authors: Oliver-Africano, Patricia; Murphy, Declan; Tyrer, Peter

Source: CNS Drugs, Volume 23, Number 11, 1 November 2009 , pp. 903-913(11)

Publisher: Adis International

Epidemiology and Management of Anxiety in Patients with Bipolar Disorder

Authors: Kauer-Sant'Anna, Marcia; Kapczinski, Flavio; Vieta, Eduard

Source: CNS Drugs, Volume 23, Number 11, 1 November 2009 , pp. 953-964(12)

Publisher: Adis International

Atypical antipsychotics in the treatment of delirium

Authors: Peritogiannis, Vaios; Stefanou, Ekaterini; Lixouriotis, Charalampos; Gkogkos, Christos; Rizos, Dimitrios V.

Source: Psychiatry and Clinical Neurosciences, Volume 63, Number 5, October 2009 , pp. 623-631(9)

Publisher: Blackwell Publishing

Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders

Authors: Gao, Keming; Sheehan, David V; Calabrese, Joseph R

Source: Expert Review of Neurotherapeutics, Volume 9, Number 8, August 2009 , pp. 1147-1158(12)

Publisher: Expert Reviews

Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications

Author: Gentile, S.

Source: Obesity Reviews, Volume 10, Number 5, September 2009 , pp. 527-542(16)

Publisher: Blackwell Publishing

Pyramidal Neurons in Rat Prefrontal Cortex Projecting to Ventral Tegmental Area and Dorsal Raphe Nucleus Express 5-HT_2A Receptors

Authors: Vzquez-Borsetti, Pablo; Corts, Roser; Artigas, Francesc

Source: Cerebral Cortex, Volume 19, Number 7, 17 July 2009 , pp. 1678-1686(9)

Publisher: Oxford University Press

The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? A Systematic Review

Authors: Smieskova, R.; Fusar-Poli, P.; Allen, P.; Bendfeldt, K.; Stieglitz, R. D.; Drewe, J.; Radue, E. W.; McGuire, P. K.; Riecher-Rossler, A.; Borgwardt, S. J.

Source: Current Pharmaceutical Design, Volume 15, Number 22, August 2009 , pp. 2535-2549(15)

Publisher: Bentham Science Publishers

What do ERPs and ERFs Reveal About the Effect of Antipsychotic Treatment on Cognition in Schizophrenia?

Authors: Korostenskaja, M.; Kahkonen, S.

Source: Current Pharmaceutical Design, Volume 15, Number 22, August 2009 , pp. 2573-2593(21)

Publisher: Bentham Science Publishers

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

Authors: Ng, Felicity; Mammen, Oommen K; Wilting, Ingeborg; Sachs, Gary S; Ferrier, I Nicol; Cassidy, Frederick; Beaulieu, Serge; Yatham, Lakshmi N; Berk, Michael

Source: Bipolar Disorders, Volume 11, Number 6, September 2009 , pp. 559-595(37)

Publisher: Blackwell Publishing

Recent progress in the pharmacotherapy of bipolar disorder

Authors: Mitchell, Philip B; Loo, Colleen K; Breakspear, Michael

Source: Future Neurology, Volume 4, Number 4, July 2009 , pp. 493-508(16)

Publisher: Future Medicine

Use of Antipsychotics among Elderly Nursing Home Residents with Dementia in the US: An Analysis of National Survey Data

Authors: Kamble, Pravin; Chen, Hua; Sherer, Jeffrey T.; Aparasu, Rajender R.

Source: Drugs & Aging, Volume 26, Number 6, 6 June 2009 , pp. 483-492(10)

Publisher: Adis International

The CATIE and CUtLASS Studies in Schizophrenia: Results and Implications for Clinicians

Authors: Naber, Dieter; Lambert, Martin

Source: CNS Drugs, Volume 23, Number 8, 8 August 2009 , pp. 649-659(11)

Publisher: Adis International